Editorial Process Disclosure

At Pharmacally, we adhere to a structured and transparent editorial process to ensure that all content published on our platform is credible, up-to-date, and valuable to our readers. Depending on the type of content, our editorial workflow may vary slightly to reflect the nature and sensitivity of the information. 

For Medical and Therapeutic Content

These include articles covering drug mechanisms, disease insights, clinical trials, diagnostics, treatment guidelines, and traditional medicine.

Contact Us

1. Topic Identification and Selection

Our editorial team monitors advancements across trusted sources:

  • Renowned medical journals (NEJM, Lancet, Nature)

  • Regulatory websites (FDA, EMA, CDSCO)

  • Physician associations (AMA, ESMO, IDSA, IMA)

  • Trusted medical news outlets

  • Social media updates from verified experts and institutions

  • Topics are selected based on medical relevance, public interest, and emerging evidence.

2. Assignment and Initial Drafting

Topics are assigned to interns, guest writers, or in-house medical writers.

Writers use tools such as:

  • AI assistance for outlining and drafting
  • Manual editing to refine tone, structure, and context
  •  Grammarly for language enhancement
  •  Plagiarism detection tools to ensure originality
  • This results in a comprehensive first draft.

3. Internal Editorial Review (Stage 1)

The editorial team reviews the first draft for:

  • Clarity, logical flow, and factual accuracy
  •  Removal of unrelated, unsupported, or controversial statements
  • Proper referencing and medical disclaimers

4. Expert Review (Stage 2)

The revised article is then reviewed by:

  • MD doctors
  •  Medical specialists
  •  Regulatory advisors
  •  Guest peer reviewers


This step ensures scientific and clinical accuracy, regulatory compliance, and ethical balance. 

5. Final Review and Proofreading (Stage 3)

The editorial team incorporates expert feedback and performs final checks:

  • Proofreading, formatting, and readability
  •  SEO optimization and meta-tagging

The article is then approved for publication and shared via our channels.

For Medical News and Regulatory Updates

  • These include:
  • FDA/EMA approvals or rejections
  • Company acquisitions or partnerships
  • Product launches
  • Policy updates
  • Industry movements
Such articles are primarily factual and time-sensitive. They do not generally require medical expert (MD) review unless the news contains significant clinical or therapeutic implications.

Editorial Review Process

  • Written by trained editorial staff or news contributors
  • Verified through official press releases, regulatory databases, and trusted news sources
  • Reviewed by Pharmacally internal editorial team for accuracy, neutrality, and clarity
  • Subject to rapid editing and publishing due to time-sensitivity
  • Minor updates or corrections are made as needed post-publication

Our Commitment

  • Whether it's an in-depth medical piece or a news update, we maintain:

Accuracy

Transparency

Professionalism

Source Attribution

  • We update articles periodically based on new information, corrections, or regulatory changes.
Scroll to Top